State of New Jersey Common Pension Fund D’s Xenon Pharmaceuticals XENE Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Buy	26,227 +6,420	+32%	+$356K	0.01%	1226
2026 Q1	$1.15M	Buy	19,807 +69	+0.3%	+$3.18K	﹤0.01%	1392
2025 Q4	$885K	Sell	19,738 -35,973	-65%	-$1.51M	﹤0.01%	1407
2025 Q3	$2.24M	Sell	55,711 -6,061	-10%	-$213K	0.01%	1044
2025 Q2	$1.93M	Buy	61,772 +11,355	+23%	+$370K	0.01%	1211
2025 Q1	$1.69M	Sell	50,417 -3,616	-7%	-$137K	0.01%	1330
2024 Q4	$2.12M	Buy	54,033 +5,460	+11%	+$226K	0.01%	1102
2024 Q3	$1.91M	Hold	48,573	–	–	0.01%	1382
2024 Q2	$1.89M	Sell	48,573 -8,177	-14%	-$327K	0.01%	1163
2024 Q1	$2.44M	Sell	56,750 -14,263	-20%	-$656K	0.01%	1479
2023 Q4	$3.27M	Buy	71,013 +6,559	+10%	+$232K	0.01%	891
2023 Q3	$2.2M	Hold	64,454	–	–	0.01%	1435
2023 Q2	$2.48M	Hold	64,454	–	–	0.01%	1342
2023 Q1	$2.31M	Hold	64,454	–	–	0.01%	1184
2022 Q4	$2.54M	Hold	64,454	–	–	0.01%	982
2022 Q3	$2.33M	Buy	+64,454	New	+$2.32M	0.01%	1018
2019 Q3	–	Sell	-155,100	Closed	-$1.53M	–	1648
2019 Q2	$1.53M	Hold	155,100	–	–	0.01%	779
2019 Q1	$1.58M	Hold	155,100	–	–	0.01%	769
2018 Q4	$979K	Hold	155,100	–	–	﹤0.01%	816
2018 Q3	$2.05M	Hold	155,100	–	–	0.01%	745
2018 Q2	$1.43M	Buy	155,100 +90,100	+139%	+$560K	0.01%	832
2018 Q1	$319K	Hold	65,000	–	–	﹤0.01%	914
2017 Q4	$184K	Hold	65,000	–	–	﹤0.01%	917
2017 Q3	$192K	Hold	65,000	–	–	﹤0.01%	928
2017 Q2	$205K	Hold	65,000	–	–	﹤0.01%	919
2017 Q1	$260K	Hold	65,000	–	–	﹤0.01%	910
2016 Q4	$501K	Hold	65,000	–	–	﹤0.01%	874
2016 Q3	$527K	Hold	65,000	–	–	﹤0.01%	865
2016 Q2	$385K	Hold	65,000	–	–	﹤0.01%	895
2016 Q1	$454K	Hold	65,000	–	–	﹤0.01%	892
2015 Q4	$523K	Hold	65,000	–	–	﹤0.01%	904
2015 Q3	$537K	Hold	65,000	–	–	﹤0.01%	893
2015 Q2	$749K	Buy	+65,000	New	+$899K	﹤0.01%	867

Other funds holding XENE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

State of New Jersey Common Pension Fund D's XENE Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its Xenon Pharmaceuticals (XENE) stake by 32% in Q2 2026, buying an estimated $356K and bringing the position to 26,227 shares worth $1.58M. The position accounts for 0.01% of the portfolio, ranked #1226.

State of New Jersey Common Pension Fund D first reported a position in XENE in Q2 2015 and has held it in 33 quarters since. The position peaked at $3.27M in Q4 2023. 96 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

State of New Jersey Common Pension Fund D held 26,227 shares of Xenon Pharmaceuticals worth $1.58M as of Q2 2026.
State of New Jersey Common Pension Fund D bought 6,420 Xenon Pharmaceuticals shares in Q2 2026, an estimated $356K.
Xenon Pharmaceuticals made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1226 holding.
State of New Jersey Common Pension Fund D first reported a position in Xenon Pharmaceuticals in Q2 2015 and has held it in 33 quarters since.
State of New Jersey Common Pension Fund D's Xenon Pharmaceuticals position peaked at $3.27M in Q4 2023.
96 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.